RARA CRAFT DATABASE for FDA Medical Devices
510(k)K220041

FDA DEVICE FACTS

HandPICO

Vydence Medical Industria E Comercio Ltda

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 5, 2022PRODUCT CODEGEX

Indications for use

IPL 390nm-510nm Filter * The treatment of inflammatory acne (acne vulgaris); * The treatment of leukoderma, including vitiligo (acquired leukoderma). IPL 400nm-1200nm Filter ¢ The treatment of moderate inflammatory acne vulgaris; + The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles); + the treatment of benign cutaneous lesions including warts, scars and striae; + The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, Poikiloderma of Civatte, leg veins and venous malformations. * Use on all skin types (Fitzpatrick I-VI). IPL 515-1200nm Filter + The treatment of moderate inflammatory acne (acne vulgaris). * The treatment of tattoos and benign pigmented epidermal and benign cutaneous lesions including warts, scars, striae, dyschromia, hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, melasma, and café-aulait macules. + The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. * The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair growth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6,9 an 12 months after the completion of a treatment regime. + Use on Fitzpatrick skin types I-V. IPL 540nm-1200nm Filter + benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), + lentigines, nevi, and cafe-au-lait macules; * the treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. * The treatment of benign cutaneous lesions including warts, scars and striae. * The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair growth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6,9 and 12 months after the completion of a treatment regime. * Use on all skin types (Fitzpatrick I-VI). IPL 580nm-1200nm Filter + The treatment of moderate inflammatory acne vulgaris. * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). + The treatment of face and body benign vascular and benign pigmented lesions.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026